| TIME | ARTICLE |
JOURNAL |
IF | PUBMED ID | PRODUCT |
|---|---|---|---|---|---|
| 2019 | AKR1C1 controls cisplatin-resistance in head and neck squamous cell carcinoma through cross-talk with the STAT1/3 signaling pathway | J Exp Clin Cancer Res. | 6.217 | 31182137 | |
| 2018 | Downregulating CD26/DPPIV by apigenin modulates the interplay between Akt and Snail/Slug signaling to restrain metastasis of lung cancer with multiple EGFR statuses | J Exp Clin Cancer Res. | 6.217 | 30134935 | |
| 2021 | Identification of Beilschmiedia tsangii Root Extract as a Liver Cancer Cell–Normal Keratinocyte Dual-Selective NRF2 Regulator | Antioxidants (Basel). | 6.312 | 33915987 | |
| 2022 | Preclinical Therapeutic Assessment of a New Chemotherapeutics Dichloro(4,4'-Bis(2,2,3,3-Tetrafluoropropoxy) Methyl)-2,2'-Bipryridine) Platinum] in an Orthotopic Patient-Derived Xenograft Model of Triple- Negative Breast Cancers | Pharmaceutics | 6.321 | ||
| 2021 | Facile Biofilm Penetration of Cationic Liposomes Loaded with DNase I/Proteinase K to Eradicate Cutibacterium acnes for Treating Cutaneous and Catheter Infections | Int J Nanomedicine. | 6.4 | 34938074 | |
| 2019 | The FLT3 inhibitor midostaurin selectively resensitizes ABCB1-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic agents | Cancer Lett. | 6.491 | 30639533 | |
| 2018 | The positive inotropic agent DPI-201106 selectively reverses ABCB1-mediated multidrug resistance in cancer cell lines | Cancer Lett. | 6.491 | 30031116 | |
| 2018 | SIS3, a specific inhibitor of Smad3 reverses ABCB1- and ABCG2-mediated multidrug resistance in cancer cell lines | Cancer Lett. | 6.491 | 30026175 | |
| 2018 | N-α-acetyltransferase 10 protein promotes metastasis by stabilizing matrix metalloproteinase-2 protein in human osteosarcomas | Cancer Lett. | 6.491 | 29960050 |
